Interested in being a part of the Diagnostic Revolution? Learn more about investment opportunities here.

Leading the Biodiagnostic Testing Revolution

We are a purpose-driven diagnostic technology company focused on helping people of all communities understand and optimize their health. Our proprietary Quantum-Logic Aptamer Analyte Detection (Q-LAAD) technology will enable the development of a hospital-grade, point-of-care testing ecosystem that offers unparalleled speed, accuracy, and accessibility.

Double blob icon

Bringing hospital-grade diagnostic solutions available at the point-of-care to everyone, everywhere.

When someone you love is sick and you don’t know why, waiting hours or even days for test results seems like an eternity. That’s if you’re one of the lucky people around the world with access to quality diagnostic testing.

Our patented Q-LAAD technology is the first revolutionary change in diagnostic testing in over 30 years. We are committed to providing a completely new dimension of diagnostic testing everywhere, for anything. Empowering people to understand their personal health and the quality of products treating their wellness.

Be A Part Of The Revolution

We are currently raising capital via a Regulatory A+ securities offering. As an early-stage investor can help Facible revolutionize diagnostic testing for people around the world. For a limited time, early investors have the opportunity to earn one bonus share for every share purchased.

Invest Now
Team in lab

About Facible.

Our mission is to help people around the world achieve optimal health and wellness regardless of where they live or their socioeconomic status by helping them know precisely what they need and ensuring the purity and quality of the products they use to optimize their health.

Meet the team